Hct Stada

Hct Stada is a prescription medication that contains the thiazide diuretic hydrochlorothiazide. It is supplied in oral tablet form (strength not specified) and is marketed in the European Union. Hydrochlorothiazide works by reducing sodium and water reabsorption in the kidneys, which helps lower blood pressure and decrease fluid buildup. Hct Stada is used under medical supervision for conditions such as hypertension and edema or related disorders.

Hct Stada is indicated for several clinical situations where reduction of excess fluid or control of blood pressure is required.

- Hypertension (high blood pressure) - Edema associated with heart failure - Edema due to liver cirrhosis - Edema due to renal disease - Adjunct therapy for resistant hypertension when combined with other antihypertensives

Side effects of Hct Stada vary in frequency; some are mild and expected, while others may require medical attention.

Common: - Increased frequency of urination - Low potassium levels (hypokalemia) - Dizziness or light‑headedness - Headache - Fatigue or weakness - Muscle cramps or aches

Serious: - Severe dehydration - Marked drop in blood pressure (hypotension) - Allergic reactions such as rash, swelling, or anaphylaxis - Blood disorders (e.g., leukopenia, thrombocytopenia) - Worsening kidney function - Acute gout attacks

Before starting Hct Stada, certain precautions should be considered to ensure safe and effective use.

- Evaluate kidney function and adjust dose if needed - Monitor serum electrolytes, especially potassium and sodium - Use cautiously in patients with a history of gout - Avoid in severe liver disease without specialist guidance - Discuss pregnancy, breastfeeding, or plans for conception with a healthcare provider - Review all current medications for potential interactions - Dose adjustments may be required for elderly patients

Hct Stada can interact with other medicines, influencing its diuretic effect or electrolyte balance.

Avoid: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may blunt diuretic response - Lithium, due to increased risk of lithium toxicity - Digoxin, because low potassium can predispose to arrhythmias - Certain antihypertensives (e.g., ACE inhibitors) that may raise potassium levels - Corticosteroids, which can enhance fluid loss

Use with caution: - Anticoagulants such as warfarin (monitor INR) - Antidiabetic agents (possible alteration of glucose control) - Other diuretics (risk of over‑diuresis and electrolyte disturbances) - Calcium channel blockers (potential additive blood pressure effect) - Specific antibiotics like aminoglycosides (monitor renal function)